Mycobacterium bovis isolates with M. tuberculosis specific characteristics

Emerging Infectious Diseases

Volumn 12, Issue 5, 2006, Pages 763-765

  Kubica, Tanja ^a   Agzamova, Rimma ^b   Wright, Abigail ^c   Rakishev, Galimzhan ^b   Rüsch Gerdes, Sabine ^a   Niemann, Stefan ^a,d  

^a German National Reference Center for Mycobacteria   (Germany)

^b National Center for Tuberculosis Problems   (Kazakhstan)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; PYRAZINAMIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; KAZAKHSTAN; MALE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

EID: 33646595658     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1205.050200     Document Type: Article

References (13)

1. Ayele WY, Neill SD, Zinsstag J, Weiss MG, Pavlik I. Bovine tuberculosis: an old disease but a new threat to Africa. Int J Tuberc Lung Dis. 2004;8:924-37.
2. Wayne LG, Kubica GP. The mycobacteria. In: Sneath PHA and Holt JG, editors. Bergeys manual of systematic bacteriology, vol. 2. Baltimore: Williams & Wilkins Co.; 1986. p. 1435-57.
3. Niemann S, Richter E, Rüsch-Gerdes S. Differentiation among members of the Mycobacterium tuberculosis complex by molecular and biochemical features: evidence for two pyrazinamide-susceptible subtypes of M. bovis. J Clin Microbiol. 2000;38:152-7.
4. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strains differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907-14.
5. Sreevatsan S, Escalante P, Pan X, Gillies DA 2nd, Siddiqui S, Khalaf CN, et al. Identification of a polymorphic nucleotide in oxyR specific for Mycobacterium bovis. J Clin Microbiol. 1996;34:2007-10.
6. Niemann S, Harmsen D, Rüsch-Gerdes S, Richter E. Differentiation of clinical Mycobacterium tuberculosis complex strains by gyrB DNA sequence polymorphism analysis. J Clin Microbiol. 2000;38:3231-4.
7. Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A. 2002;99:3684-9.
8. Huard RC, de Oliveira Lazzarini LC, Butler WR, van Soolingen D, Ho JL. PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions. J Clin Microbiol. 2003;41:1637-50.
9. Mostowy S, Cousins D, Brinkman J, Aranaz A, Behr MA. Genomic deletions suggest a phylogeny for the Mycobacterium tuberculosis complex. J Infect Dis. 2002;186:74-80.
10. Kubica T, Agzamova R, Wright A, Aziz MS, Rakishev G, Bismilda V, et al. The Beijing genotype is a major cause of drug resistant tuberculosis in Kazakhstan. Int J Tuberc Lung Dis. 2005; 9:646-53.
11. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406-9.
12. Talbot EA, Williams DL, Frothingham R. PCR identification of Mycobacterium bovis BCG. J Clin Microbiol. 1997;35:566-9.
13. Kubica T, Rüsch-Gerdes S, Niemann S. Mycobacterium bovis subsp. caprae caused one-third of human M. bovis-associated tuberculosis cases reported in Germany between 1999 and 2001. J Clin Microbiol. 2003;41:3070-7.